Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

por Gillette, Michael A, Carr, Steven A
Publicado 2013

Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

por Gillette, Michael, Taylor, Addison, Butulija, Djenita, Kadiyala, Himabindu, Jneid, Hani
Publicado en Cardiovasc Drugs Ther (2020)

Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry

por Burgess, Michael W., Keshishian, Hasmik, Mani, D. R., Gillette, Michael A., Carr, Steven A.
Publicado 2014

Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

por Pickett, June K., Shah, Maulin, Gillette, Michael, Jones, Peter, Virani, Salim, Ballantyne, Christie, Nambi, Vijay
Publicado en JACC Case Rep (2020)

Accurate Inclusion Mass Screening: A Bridge from Unbiased Discovery to Targeted Assay Development for Biomarker Verification

por Jaffe, Jacob D., Keshishian, Hasmik, Chang, Betty, Addona, Theresa A., Gillette, Michael A., Carr, Steven A.
Publicado 2008

Metagene projection for cross-platform, cross-species characterization of global transcriptional states

por Tamayo, Pablo, Scanfeld, Daniel, Ebert, Benjamin L., Gillette, Michael A., Roberts, Charles W. M., Mesirov, Jill P.
Publicado 2007

Leukocytosis in Patients with Neurologic Deterioration after Acute Ischemic Stroke is Associated with Poor Outcomes

por Kumar, Andre D., Boehme, Amelia K., Siegler, James E., Gillette, Michael, Albright, Karen C., Martin-Schild, Sheryl
Publicado en J Stroke Cerebrovasc Dis (2012)

PEPPeR: A Platform for Experimental Proteomic Pattern Recognition

por Jaffe, Jacob D., Mani, D. R., Leptos, Kyriacos C., Church, George M., Gillette, Michael A., Carr, Steven A.
Publicado 2009

What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?

por Siegler, James E., Boehme, Amelia K., Kumar, Andre D., Gillette, Michael A., Albright, Karen C., Martin-Schild, Sheryl
Publicado en J Stroke Cerebrovasc Dis (2012)

Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry

por Keshishian, Hasmik, Burgess, Michael W, Specht, Harrison, Wallace, Luke, Clauser, Karl R, Gillette, Michael A, Carr, Steven A
Publicado en Nat Protoc (2017)

Identification of modifiable and non-modifiable risk factors for neurological deterioration following acute ischemic stroke

por Siegler, James E., Boehme, Amelia K., Kumar, Andre D., Gillette, Michael A., Albright, Karen C., Beasley, T. Mark, Martin-Schild, Sheryl
Publicado 2012

Persistent Leukocytosis—Is this a Persistent Problem for Patients with Acute Ischemic Stroke?

por Boehme, Amelia K., Kumar, Andre D., Lyerly, Michael J., Gillette, Michael A., Siegler, James E., Albright, Karen C., Beasley, T. Mark, Martin-Schild, Sheryl
Publicado en J Stroke Cerebrovasc Dis (2014)

Time to Neurological Deterioration in Ischemic Stroke

por Siegler, James E., Albright, Karen C., George, Alexander J., Boehme, Amelia K., Gillette, Michael A., Kumar, Andre D., Aswani, Monica, Martin-Schild, Sheryl
Publicado en Med Student Res J (2017)

A Human Proteome Detection and Quantitation Project

por Anderson, N. Leigh, Anderson, Norman G., Pearson, Terry W., Borchers, Christoph H., Paulovich, Amanda G., Patterson, Scott D., Gillette, Michael, Aebersold, Ruedi, Carr, Steven A.
Publicado 2009

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

por Subramanian, Aravind, Tamayo, Pablo, Mootha, Vamsi K., Mukherjee, Sayan, Ebert, Benjamin L., Gillette, Michael A., Paulovich, Amanda, Pomeroy, Scott L., Golub, Todd R., Lander, Eric S., Mesirov, Jill P.
Publicado 2005

Integrated proteomic analysis of post-translational modifications by serial enrichment

por Mertins, Philipp, Qiao, Jana W, Patel, Jinal, Udeshi, Namrata D, Clauser, Karl R, Mani, D R, Burgess, Michael W, Gillette, Michael A, Jaffe, Jacob D, Carr, Steven A
Publicado 2013

Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury

por Keshishian, Hasmik, Burgess, Michael W., Gillette, Michael A., Mertins, Philipp, Clauser, Karl R., Mani, D. R., Kuhn, Eric W., Farrell, Laurie A., Gerszten, Robert E., Carr, Steven A.
Publicado en Mol Cell Proteomics (2015)

Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium

por Ellis, Matthew J., Gillette, Michael, Carr, Steven A., Paulovich, Amanda G., Smith, Richard D., Rodland, Karin K., Townsend, R. Reid, Kinsinger, Christopher, Mesri, Mehdi, Rodriguez, Henry, Liebler, Daniel C.
Publicado 2013

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

por Addona, Terri A, Shi, Xu, Keshishian, Hasmik, Mani, D R, Burgess, Michael, Gillette, Michael A, Clauser, Karl R, Shen, Dongxiao, Lewis, Gregory D, Farrell, Laurie A, Fifer, Michael A, Sabatine, Marc S, Gerszten, Robert E, Carr, Steven A
Publicado 2011

A Curated Resource for Phosphosite-specific Signature Analysis

por Krug, Karsten, Mertins, Philipp, Zhang, Bin, Hornbeck, Peter, Raju, Rajesh, Ahmad, Rushdy, Szucs, Matthew, Mundt, Filip, Forestier, Dominique, Jane-Valbuena, Judit, Keshishian, Hasmik, Gillette, Michael A., Tamayo, Pablo, Mesirov, Jill P., Jaffe, Jacob D., Carr, Steven A., Mani, D. R.
Publicado en Mol Cell Proteomics (2019)